406-420 of 516
FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
FDA Drug Information UpdatesFDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
Rethinking Nicotine: The Campaign to Break the World's Tobacco Habit
Primary Care TodayRethinking Nicotine: The Campaign to Break the World's Tobacco Habit
What is Idiopathic Pulmonary Fibrosis (IPF)?
Video LibraryWhat is Idiopathic Pulmonary Fibrosis (IPF)?
The Importance of Early Referral and Treatment for IPF
Video LibraryThe Importance of Early Referral and Treatment for IPF
Beyond the Data: E-cigarettes, an Emerging Public Health Challenge
Grand Rounds Nation®Beyond the Data: E-cigarettes, an Emerging Public Health Challenge
- advertisement
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
Project Oncology®FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
Project Oncology®FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
Q&A with Penn Medicine Experts: Hot Topics in Primary Care
Medical Breakthroughs from Penn MedicineQ&A with Penn Medicine Experts: Hot Topics in Primary Care
A Thoracic Surgeon's Viewpoint on Screening, Diagnosis and Treatment of a Lung Cancer Patient
Medical Breakthroughs from Penn MedicineA Thoracic Surgeon's Viewpoint on Screening, Diagnosis and Treatment of a Lung Cancer Patient
Journal of Cystic Fibrosis: Efficacy and Safety of Levofloxacin Inhalation Solution (APT-1026) in Stable Cystic Fibrosis Patients
AudioAbstractsJournal of Cystic Fibrosis: Efficacy and Safety of Levofloxacin Inhalation Solution (APT-1026) in Stable Cystic Fibrosis Patients
Journal of Cystic Fibrosis: Microbial Colonization and Lung Function in Adolescents With Cystic Fibrosis
AudioAbstractsJournal of Cystic Fibrosis: Microbial Colonization and Lung Function in Adolescents With Cystic Fibrosis
- advertisement
Cell Death and Differentiation: A Novel Treatment of Cystic Fibrosis Acting On-Target
AudioAbstractsCell Death and Differentiation: A Novel Treatment of Cystic Fibrosis Acting On-Target
Bronchitis Symptoms and Treatment Considerations
What Your Patients Are Talking AboutBronchitis Symptoms and Treatment Considerations
Who is at Risk for Pulmonary Arterial Hypertension (PAH)?
Medical Breakthroughs from Penn MedicineWho is at Risk for Pulmonary Arterial Hypertension (PAH)?













































